Search results

The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.

Three new federal grants were announced to support manufacturing and nuclear technologies.

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program

ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).

International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

Researchers developing new materials and devices that can withstand the harsh radiation environment in space are using the unique ANSTO’s capability to simulate the effects of high-energy ion irradiation on the properties and performance of these materials and devices.

The health impacts of exposure to poor levels of air quality resulting from bushfires and drought recommended that NSW Government work with ANSTO to expand the sampling of particulate matter in the air state-wide.

Today an international team has provided a molecular basis for strong immunity against COVID-19.